Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Mallinckrodt Plc (MNK)

Mallinckrodt Plc (MNK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Keenova Reports First Quarter 2026 Financial Results PR Newswire - Tue May 12, 5:30AM CDT

Strong First-Quarter Performance Driven by Acthar ® Gel 1  and XIAFLEX ® 2

MNK : 0.3402 (-14.97%)
Keenova Launches New Consumer Campaign for Dupuytren's Contracture: Don't Be a Viking PR Newswire - Mon May 4, 6:30AM CDT

Dupuytren's contracture, a.k.a. Viking Hand, is a progressive hand condition affecting an estimated 13 million Americans

MNK : 0.3402 (-14.97%)
Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at Digestive Disease Week PR Newswire - Fri May 1, 6:30AM CDT

DUBLIN , May 1, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a new presentation on hepatorenal syndrome-acute kidney injury (HRS‑AKI) and TERLIVAZ ® (terlipressin) will...

MNK : 0.3402 (-14.97%)
Keenova Therapeutics to Report First Quarter 2026 Financial Results on May 12, 2026 PR Newswire - Thu Apr 30, 6:00AM CDT

DUBLIN , April 30, 2026 /PRNewswire/ --  Keenova Therapeutics plc , a leading developer and manufacturer of branded therapeutics, announced today that it will report its first quarter 2026 financial...

MNK : 0.3402 (-14.97%)
Keenova Announces Unaudited Fourth Quarter 2025 Financial Results PR Newswire - Tue Mar 31, 5:30AM CDT

Robust Fourth-Quarter Performance Driven by Strength in Acthar ® Gel 1  and XIAFLEX ® 2

MNK : 0.3402 (-14.97%)
Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at the SHM Converge PR Newswire - Fri Mar 27, 6:30AM CDT

DUBLIN , March 27, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a new presentation on hepatorenal syndrome-acute kidney injury (HRS‑AKI) and TERLIVAZ ® (terlipressin)...

MNK : 0.3402 (-14.97%)
Keenova Publishes XIAFLEX® (collagenase clostridium histolyticum) Analysis in Journal of Hand Surgery Global Online PR Newswire - Tue Mar 3, 6:30AM CST

Manuscript appears in a peer-reviewed journal for the first time

MNK : 0.3402 (-14.97%)
Keenova Unveils Clinical Data from Phase 2 Plantar Fibromatosis Study at the ACFAS Annual Meeting PR Newswire - Tue Feb 24, 6:30AM CST

DUBLIN , Feb. 24, 2026 /PRNewswire/ -- Keenova Therapeutics plc is presenting clinical data on plantar fibromatosis at the American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting, taking...

MNK : 0.3402 (-14.97%)
Keenova Announces New Manuscript on Plantar Fibromatosis Treatment Patterns in Peer-Reviewed Journal of Foot and Ankle Surgery PR Newswire - Mon Feb 16, 6:30AM CST

DUBLIN , Feb. 16, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced the publication of a new manuscript presenting real-world evidence on treatment patterns for patients with plantar fibromatosis....

MNK : 0.3402 (-14.97%)
Keenova Marks 100K Peyronie's Disease Patients--a Major Milestone for an Often-Stigmatized Men's Health Condition PR Newswire - Wed Jan 21, 6:30AM CST

DUBLIN , Jan. 21, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that it reached a milestone: 100,000 patients with Peyronie's disease (PD) have been prescribed XIAFLEX ®...

MNK : 0.3402 (-14.97%)

Barchart Exclusives

Yield Is No Longer King: What These 5 Dividend ETFs Are Telling Investors Barchart - Wed May 13, 6:30PM CDT
Dividend investing has changed, and yield is misunderstood or misused by many investors. Let's take a closer look at 5 ETFS and discuss what dividend investors should know. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.